Physician

Uzoma Nwakuche, MD

According to 2025 Medicare claims, Uzoma Nwakuche, MD (NPI: 1427217645) practices hematology/oncology in the Gettysburg, PA market, with the plurality of this provider's patient population coming from Adams, PA. This provider's primary affiliated billing organization is GOOD SAMARITAN PHYSICIAN SERVICES (NPI: 1790551000; TIN: 232730785) and primary practice location at 17325-7878. Nwakuche is affiliated with the WellSpan Population Health Services (ACO ID: A2500), participating under the MSSP model.

Nwakuche's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 497 traditional Medicare patients, billed 1,250 HCPCS/CPT codes, and received $149,045 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,441 prescription claims across 238 beneficiaries totaling $4,206,723 in drug costs, led by Lenalidomide (Lenalidomide). DME data shows 37 claims. Open Payments data shows 2 records totaling $151. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $53,737 to $149,045. Similarly, Part D prescription costs have risen steadily, from $626,264 to $4,206,723. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $2,736 and ending at $2,685.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	315	929	$53,737
2016	498	1,316	$76,610
2017	422	806	$38,567
2018	309	945	$80,968
2019	351	1,192	$108,105
2020	401	1,139	$116,059
2021	463	1,338	$161,870
2022	449	1,295	$154,452
2023	517	1,330	$159,673
2024	497	1,250	$149,045

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	88	546	$626,264
2016	159	769	$1,226,037
2017	144	751	$2,480,191
2018	116	565	$1,434,966
2019	123	766	$1,418,053
2020	160	963	$2,153,558
2021	149	827	$1,805,272
2022	176	964	$1,800,596
2023	178	833	$2,048,165
2024	238	1,441	$4,206,723

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	60	$1,257
2017	N/R	101	$3,761
2018	N/R	116	$8,902
2019	N/R	160	$10,939
2020	N/R	66	$3,651
2021	N/R	258	$16,757
2022	N/R	164	$9,020
2023	N/R	90	$7,509
2024	N/R	37	$1,954

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	81	81	$161
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	337	921	$126
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	35	35	$112
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	135	160	$78
38222	Biopsy and aspiration of bone marrow sample for diagnosis	24	26	$48

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	58	1,617	$677,041
Revlimid	Lenalidomide	23	637	$392,977
Verzenio	Abemaciclib	24	672	$389,141
Venclexta	Venetoclax	21	628	$309,518
Abiraterone Acetate	Abiraterone Acetate	65	1,950	$249,304

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	N/R	12	$939
J8530	Cyclophosphamide; oral, 25 mg	N	N/R	13	$789
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	12	$226

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$151	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Uzoma Nwakuche, MD?

Tedicare shows public-source Medicare data for Uzoma Nwakuche, MD (NPI 1427217645), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Uzoma Nwakuche, MD have ACO affiliation data?

Uzoma Nwakuche, MD is shown with ACO affiliation data for WellSpan Population Health Services (MSSP, ACO ID A2500).

What billing organization is linked to Uzoma Nwakuche, MD?

Uzoma Nwakuche, MD is linked to GOOD SAMARITAN PHYSICIAN SERVICES (billing NPI 1790551000) in the available physician profile data.

Does Uzoma Nwakuche, MD have Open Payments data?

Uzoma Nwakuche, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.